Delaporte E - Search Results

1

Clinical Impact of Pretreatment Human Immunodeficiency Virus Drug Resistance in People Initiating Nonnucleoside Reverse Transcriptase Inhibitor-Containing Antiretroviral Therapy: A Systematic Review and Meta-analysis.

Bertagnolio S, Hermans L, Jordan MR, Avila-Rios S, Iwuji C, Derache A, Delaporte E, Wensing A, Aves T, Borhan ASM, Leenus A, Parkin N, Doherty M, Inzaule S, Mbuagbaw L. Bertagnolio S, et al. Among authors: delaporte e. J Infect Dis. 2021 Aug 2;224(3):377-388. doi: 10.1093/infdis/jiaa683. J Infect Dis. 2021. PMID: 33202025 Free PMC article. Review.

2

Resistance to antiretroviral treatment in Gabon: need for implementation of guidelines on antiretroviral therapy use and HIV-1 drug resistance monitoring in developing countries.

Vergne L, Malonga-Mouellet G, Mistoul I, Mavoungou R, Mansaray H, Peeters M, Delaporte E. Vergne L, et al. Among authors: delaporte e. J Acquir Immune Defic Syndr. 2002 Feb 1;29(2):165-8. doi: 10.1097/00042560-200202010-00009. J Acquir Immune Defic Syndr. 2002. PMID: 11832686

3

No difference in clinical progression between patients infected with the predominant human immunodeficiency virus type 1 circulating recombinant form (CRF) 02_AG strain and patients not infected with CRF02_AG, in Western and West-Central Africa: a four-year prospective multicenter study.

Laurent C, Bourgeois A, Faye MA, Mougnutou R, Seydi M, Gueye M, Liégeois F, Kane CT, Butel C, Mbuagbaw J, Zekeng L, Mboup S, Mpoudi-Ngolé E, Peeters M, Delaporte E. Laurent C, et al. Among authors: delaporte e. J Infect Dis. 2002 Aug 15;186(4):486-92. doi: 10.1086/341833. Epub 2002 Jul 19. J Infect Dis. 2002. PMID: 12195375

4

Low rate of genotypic HIV-1 drug-resistant strains in the Senegalese government initiative of access to antiretroviral therapy.

Vergne L, Kane CT, Laurent C, Diakhaté N, Gueye NF, Gueye PM, Sow PS, Faye MA, Liégeois F, Ndir A, Lanièce I, Peeters M, Ndoye I, Mboup S, Delaporte E. Vergne L, et al. Among authors: delaporte e. AIDS. 2003 Jul;17 Suppl 3:S31-8. doi: 10.1097/00002030-200317003-00005. AIDS. 2003. PMID: 14565607

5

Comparison of drug resistance mutations and their interpretation in patients infected with non-B HIV-1 variants and matched patients infected with HIV-1 subtype B.

Montes B, Vergne L, Peeters M, Reynes J, Delaporte E, Segondy M. Montes B, et al. Among authors: delaporte e. J Acquir Immune Defic Syndr. 2004 Apr 1;35(4):329-36. doi: 10.1097/00126334-200404010-00001. J Acquir Immune Defic Syndr. 2004. PMID: 15097148

6

Antiretroviral therapy in public and private routine health care clinics in Cameroon: lessons from the Douala antiretroviral (DARVIR) initiative.

Laurent C, Meilo H, Guiard-Schmid JB, Mapouré Y, Noël JM, M'Bangué M, Joko A, Rozenbaum W, Ntoné FN, Delaporte E. Laurent C, et al. Among authors: delaporte e. Clin Infect Dis. 2005 Jul 1;41(1):108-11. doi: 10.1086/430712. Epub 2005 May 17. Clin Infect Dis. 2005. PMID: 15937770

7

Natural polymorphism in protease and reverse transcriptase genes and in vitro antiretroviral drug susceptibilities of non-B HIV-1 strains from treatment-naive patients.

Vergne L, Stuyver L, Van Houtte M, Butel C, Delaporte E, Peeters M. Vergne L, et al. Among authors: delaporte e. J Clin Virol. 2006 May;36(1):43-9. doi: 10.1016/j.jcv.2006.01.012. Epub 2006 Mar 24. J Clin Virol. 2006. PMID: 16563858

8

Antiretroviral drug resistance and routine therapy, Cameroon.

Laurent C, Kouanfack C, Vergne L, Tardy M, Zekeng L, Noumsi N, Butel C, Bourgeois A, Mpoudi-Ngolé E, Koulla-Shiro S, Peeters M, Delaporte E. Laurent C, et al. Among authors: delaporte e. Emerg Infect Dis. 2006 Jun;12(6):1001-4. doi: 10.3201/eid1206.050860. Emerg Infect Dis. 2006. PMID: 16707062 Free PMC article.

9

HIV-1 drug-resistance mutations among newly diagnosed patients before scaling-up programmes in Burkina Faso and Cameroon.

Vergne L, Diagbouga S, Kouanfack C, Aghokeng A, Butel C, Laurent C, Noumssi N, Tardy M, Sawadogo A, Drabo J, Hien H, Zekeng L, Delaporte E, Peeters M. Vergne L, et al. Among authors: delaporte e. Antivir Ther. 2006;11(5):575-9. Antivir Ther. 2006. PMID: 16964825

10

HIV type 1 diversity and antiretroviral drug resistance mutations in Burundi.

Vidal N, Niyongabo T, Nduwimana J, Butel C, Ndayiragije A, Wakana J, Nduwimana M, Delaporte E, Peeters M. Vidal N, et al. Among authors: delaporte e. AIDS Res Hum Retroviruses. 2007 Jan;23(1):175-80. doi: 10.1089/aid.2006.0126. AIDS Res Hum Retroviruses. 2007. PMID: 17263648

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

724 results

Search Page